Opinion/decision on a Paediatric investigation plan (PIP): Imvanex, Modified Vaccinia Ankara - Bavarian Nordic virus (smallpox), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number:…
P/0284/2023 : EMA decision of 14 July 2023 on the acceptance of a modification of an agreed paediatric investigation plan for modified vaccinia Ankara - Bavarian Nordic virus (smallpox) (Imvanex), (EMEA-001161-PIP02-11-M03)
Reference Number: EMA/288064/2023
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.